Brhane Gebrehiwot Welegebrial
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brhane Gebrehiwot Welegebrial has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Gebru Gebremeskel Gebrerufael
Department of Statistics, College of Natural and Computational Sciences, Adigrat University, Adigrat, Ethiopia
5 shared publications - Gebretekle Gebremichael Hailesilase
Department of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia
3 shared publications - Abrahaley Mulu Kidane
Department of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia
2 shared publications - Haylay Araya Gebrezgabiher
Department of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia
2 shared publications - Mehari Gebre Teklezgi
Department of Statistics, College of Natural Science, Adigrat University, Adigrat, Ethiopia
2 shared publications - Samrawit Kidanemariam Gebrekidan
Department of Pharmacy, College of Medicine and Health Sciences, Adigrat University, Adigrat, Ethiopia
2 shared publications
Latest Publications
- Open Access
- 13 October 2026
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 27 (1) , 141
Correction to: In vitro comparative quality evaluation of different brands of metformin hydrochloride tablets available in Mekelle City, Tigray Regional State, Ethiopia
- 13 October 2026
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 27 (1) , 141
Open AccessCorrection to: In vitro comparative quality evaluation of different brands of metformin hydrochloride tablets available in Mekelle City, Tigray Regional State, Ethiopia
- Open Access
- 12 March 2026
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 27 (1)
In vitro comparative quality evaluation of different brands of metformin hydrochloride tablets available in Mekelle City, Tigray Regional State, Ethiopia
Background: Administration of poor-quality medications can result in various effects that jeopardize the drugs’ safety and effectiveness. Due to a lack of adequate post-market surveillance studies, making decisions regarding the quality of medicines, including metformin hydrochloride tablets, available in Mekelle City is challenging. Thus, the aim of the study was to evaluate the quality of different brands of metformin hydrochloride tablets sold in Mekelle City, Tigray Regional State, Ethiopia. Methods: A total of eight brands of 500 mg metformin hydrochloride tablets were collected from drug retail outlets in Mekelle City. In vitro quality control tests were conducted based on the WHO visual inspection tool and United States Pharmacopeia (USP) specifications. These included visual inspection, weight variation, thickness, hardness, friability, disintegration time, dissolution, and an assay of active ingredient. One-way ANOVA was used to compare all parameters of quality control. A difference was deemed statistically significant when P < 0.05. One-way ANOVA, model-independent approaches, and model-dependent approaches were used to compare the dissolution profiles and to determine the nature of active pharmaceutical ingredient release. Results: This study showed that all metformin hydrochloride brands marketed in Mekelle City complied with the WHO visual inspection and USP specifications for visual inspection, weight variation, friability, disintegration time, and assay of the active ingredient. Of the samples tested, brand E and brand F exhibited the highest and lowest hardness values, respectively, at 313.88 N and 10.06 N. Moreover, all eight brands evaluated released more than 80% of their drug contents within 30 min as outlined in the USP. However, the difference factor (f 1 ) and similarity factor (f 2 ) have indicated that only brands A, E, and H were similar (can be used interchangeably) with the comparator product. Weibull release model suits the drug release data, which had the highest correlation coefficient. Conclusions: All brands met pharmacopoeial specifications, but significant variations in hardness and dissolution profiles were observed, with only three brands showing profile similarity to the comparator. Hence, the finding serves as an alert to examine the dossier evaluations and legal approval processes of the Ethiopian Food and Drug Authority.
- 12 March 2026
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 27 (1)
Open AccessIn vitro comparative quality evaluation of different brands of metformin hydrochloride tablets available in Mekelle City, Tigray Regional State, Ethiopia
Background: Administration of poor-quality medications can result in various effects that jeopardize the drugs’ safety and effectiveness. Due to a lack of adequate post-market surveillance studies, making decisions regarding the quality of medicines, including metformin hydrochloride tablets, available in Mekelle City is challenging. Thus, the aim of the study was to evaluate the quality of different brands of metformin hydrochloride tablets sold in Mekelle City, Tigray Regional State, Ethiopia. Methods: A total of eight brands of 500 mg metformin hydrochloride tablets were collected from drug retail outlets in Mekelle City. In vitro quality control tests were conducted based on the WHO visual inspection tool and United States Pharmacopeia (USP) specifications. These included visual inspection, weight variation, thickness, hardness, friability, disintegration time, dissolution, and an assay of active ingredient. One-way ANOVA was used to compare all parameters of quality control. A difference was deemed statistically significant when P < 0.05. One-way ANOVA, model-independent approaches, and model-dependent approaches were used to compare the dissolution profiles and to determine the nature of active pharmaceutical ingredient release. Results: This study showed that all metformin hydrochloride brands marketed in Mekelle City complied with the WHO visual inspection and USP specifications for visual inspection, weight variation, friability, disintegration time, and assay of the active ingredient. Of the samples tested, brand E and brand F exhibited the highest and lowest hardness values, respectively, at 313.88 N and 10.06 N. Moreover, all eight brands evaluated released more than 80% of their drug contents within 30 min as outlined in the USP. However, the difference factor (f 1 ) and similarity factor (f 2 ) have indicated that only brands A, E, and H were similar (can be used interchangeably) with the comparator product. Weibull release model suits the drug release data, which had the highest correlation coefficient. Conclusions: All brands met pharmacopoeial specifications, but significant variations in hardness and dissolution profiles were observed, with only three brands showing profile similarity to the comparator. Hence, the finding serves as an alert to examine the dossier evaluations and legal approval processes of the Ethiopian Food and Drug Authority.
- Open Access
- 5 November 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-11
Time-to-death and its predictors among under five children in the developing regions of ethiopia: a cross sectional study
Background: The under-five children mortality rate (U5CM) is still a global public health concern, especially in Ethiopia and other countries in Sub-Saharan Africa (SSA). Unfortunately, the issue is notably underestimated and underreported, making it difficult to fully assess the severity of the crisis in the nation-state’s emerging regions. Regrettably, no research has been done to determine the time-to-death and its predictors for children under five in the developing regions of Ethiopia. Thus, the aim of this study was to determine the time-to-death and its predictor factors among children under five years old in the developing regions of Ethiopia from March 21, 2019, to June 28, 2019. Methods: This is a secondary analysis of data collected in a cross-sectional study that was done among under-five children in the developing regions of Ethiopia between March 21, 2019, and June 28, 2019. The Kaplan-Meier (K-M) survival curve was utilized to display the statistically significant variance across categorical variables, and the survival time was evaluated using the log-rank test. The Cox Proportional Hazards (PH) regression model analysis of bivariable and multivariable variables was fitted to identify the predictor factors of time-to-death. The investigation’s findings were presented utilizing tables, text, graphs, and charts. The degree of significance was determined using an adjusted hazard ratio (AHR) with a 95% confidence interval (CI) and a p-value less than 0.05. Results: In the study, a total of 2,019 children under five were included. The overall under-five child mortality rate in developing regions of Ethiopia was 8.1% (95% CI 7.0%, 9.4%). In the multivariable Cox PH regression model analysis, multiple birth type (AHR: 2.9, 95% CI: 1.34, 6.46), mothers being AntiNatal Care (ANC) follow-up (AHR: 2.0; 95% CI: 1.08, 3.87), not initiating exclusive breastfeeding (AHR: 2.7, 95% CI: 1.23, 5.78), the female sex of the child (AHR: 0.56, 95% CI: 0.333, 0.934), and the head of household being female (AHR: 0.47, 95% CI: 0.236, 0.923) were recognized as main predictors of time-to-death among under five-children. Conclusions: The study highlights an important under-five child mortality rate of 8.1% in the developing regions of Ethiopia. Important predictors identified through multivariable Cox Proportional (PH) regression model analysis include multiple birth type, lack of mother’s antenatal care (ANC) follow-up, the child’s sex, gender of household head, and failure to begin exclusive breastfeeding. Therefore, in order to decrease the high rate of mortality among children under five, the government should emphasize improvement of the ANC services, promote exclusive breastfeeding, make a targeted intervention for multiple births, and support female households in the developing regions of Ethiopia.
- 5 November 2025
- Published by Springer Nature in BMC Pediatrics
- Vol. 25 (1) , 1-11
Open AccessTime-to-death and its predictors among under five children in the developing regions of ethiopia: a cross sectional study
Background: The under-five children mortality rate (U5CM) is still a global public health concern, especially in Ethiopia and other countries in Sub-Saharan Africa (SSA). Unfortunately, the issue is notably underestimated and underreported, making it difficult to fully assess the severity of the crisis in the nation-state’s emerging regions. Regrettably, no research has been done to determine the time-to-death and its predictors for children under five in the developing regions of Ethiopia. Thus, the aim of this study was to determine the time-to-death and its predictor factors among children under five years old in the developing regions of Ethiopia from March 21, 2019, to June 28, 2019. Methods: This is a secondary analysis of data collected in a cross-sectional study that was done among under-five children in the developing regions of Ethiopia between March 21, 2019, and June 28, 2019. The Kaplan-Meier (K-M) survival curve was utilized to display the statistically significant variance across categorical variables, and the survival time was evaluated using the log-rank test. The Cox Proportional Hazards (PH) regression model analysis of bivariable and multivariable variables was fitted to identify the predictor factors of time-to-death. The investigation’s findings were presented utilizing tables, text, graphs, and charts. The degree of significance was determined using an adjusted hazard ratio (AHR) with a 95% confidence interval (CI) and a p-value less than 0.05. Results: In the study, a total of 2,019 children under five were included. The overall under-five child mortality rate in developing regions of Ethiopia was 8.1% (95% CI 7.0%, 9.4%). In the multivariable Cox PH regression model analysis, multiple birth type (AHR: 2.9, 95% CI: 1.34, 6.46), mothers being AntiNatal Care (ANC) follow-up (AHR: 2.0; 95% CI: 1.08, 3.87), not initiating exclusive breastfeeding (AHR: 2.7, 95% CI: 1.23, 5.78), the female sex of the child (AHR: 0.56, 95% CI: 0.333, 0.934), and the head of household being female (AHR: 0.47, 95% CI: 0.236, 0.923) were recognized as main predictors of time-to-death among under five-children. Conclusions: The study highlights an important under-five child mortality rate of 8.1% in the developing regions of Ethiopia. Important predictors identified through multivariable Cox Proportional (PH) regression model analysis include multiple birth type, lack of mother’s antenatal care (ANC) follow-up, the child’s sex, gender of household head, and failure to begin exclusive breastfeeding. Therefore, in order to decrease the high rate of mortality among children under five, the government should emphasize improvement of the ANC services, promote exclusive breastfeeding, make a targeted intervention for multiple births, and support female households in the developing regions of Ethiopia.
- Open Access
- 17 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0315400
Predictors of neonatal mortality among neonates in Tigray regional state, Ethiopia: A cross-sectional study
Background: Since 2015, Ethiopia is committed to lowering the death rate for children under five and it is one of the countries in Sub-Saharan Africa that has accomplished the fourth Millennium Development Goal. However, in Ethiopia, neonatal death has remained a serious public health concern, with greater rates found in Tigray regional state and the predictors aren’t well recognized. The goal of this study was to ascertain the prevalence of neonatal death in the Tigray regional State as well as any relevant risk factors. Methods: This study performed a secondary data analysis of the 2016 Ethiopia Demographic and Health Survey (EDHS) report. Information was gathered on 716 neonates who were born five years before the survey began. Risk factors for neonatal mortality were thought to include mother and neonate demographics, health, and environmental factors. The study employed multivariable logistic regression model analysis and descriptive statistics to identify significant correlates of neonatal mortality. Results: In Tigray regional state, the overall prevalence of neonatal mortality was 4.3% (95% CI: 3.06, 6.10). The multivariable logistic regression model analysis revealed that factors such as multiple birth types (AOR = 15.3, 95% CI: 3.54, 65.84), birth order (2–4) (AOR = 4.88, 95% CI: 1.52, 15.7), sex of the neonate (being male) (AOR = 3.75, 95% CI: 1.45, 9.75), home place of delivery (AOR = 7.4, 95% CI: 2.0, 27.6), and neonates born to mothers aged 20–34 years (AOR = 0.23, 95% CI: 0.087, 0.58) were significantly risk factors associated with a higher risk of neonatal mortality rate. Conclusions: The study recognized the sex of the neonate, birth order, mother’s age, place of delivery, and birth type as potential risk factors for neonatal mortality. The prevalence of neonatal mortality indicated that the neonatal mortality rate in Tigray regional state was higher than the national average. To reduce neonatal mortality, targeted interventions should focus on high-risk groups, such as mothers delivering at home and those with multiple births.
- 17 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0315400
Open AccessPredictors of neonatal mortality among neonates in Tigray regional state, Ethiopia: A cross-sectional study
Background: Since 2015, Ethiopia is committed to lowering the death rate for children under five and it is one of the countries in Sub-Saharan Africa that has accomplished the fourth Millennium Development Goal. However, in Ethiopia, neonatal death has remained a serious public health concern, with greater rates found in Tigray regional state and the predictors aren’t well recognized. The goal of this study was to ascertain the prevalence of neonatal death in the Tigray regional State as well as any relevant risk factors. Methods: This study performed a secondary data analysis of the 2016 Ethiopia Demographic and Health Survey (EDHS) report. Information was gathered on 716 neonates who were born five years before the survey began. Risk factors for neonatal mortality were thought to include mother and neonate demographics, health, and environmental factors. The study employed multivariable logistic regression model analysis and descriptive statistics to identify significant correlates of neonatal mortality. Results: In Tigray regional state, the overall prevalence of neonatal mortality was 4.3% (95% CI: 3.06, 6.10). The multivariable logistic regression model analysis revealed that factors such as multiple birth types (AOR = 15.3, 95% CI: 3.54, 65.84), birth order (2–4) (AOR = 4.88, 95% CI: 1.52, 15.7), sex of the neonate (being male) (AOR = 3.75, 95% CI: 1.45, 9.75), home place of delivery (AOR = 7.4, 95% CI: 2.0, 27.6), and neonates born to mothers aged 20–34 years (AOR = 0.23, 95% CI: 0.087, 0.58) were significantly risk factors associated with a higher risk of neonatal mortality rate. Conclusions: The study recognized the sex of the neonate, birth order, mother’s age, place of delivery, and birth type as potential risk factors for neonatal mortality. The prevalence of neonatal mortality indicated that the neonatal mortality rate in Tigray regional state was higher than the national average. To reduce neonatal mortality, targeted interventions should focus on high-risk groups, such as mothers delivering at home and those with multiple births.
- Open Access
- 18 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Prevalence of diarrheal and its associated factors among children aged under-five years in Amhara Regional State, Ethiopia: a cross-sectional study
Diarrhea is a major health problem in Ethiopia, and the Amhara Regional State is experiencing the highest prevalence rate of diarrhea. Therefore, this study was designed to assess the prevalence and risk factors attributed to diarrhea among children under-five in the Amhara Regional State. The study employed descriptive statistics and multivariable logistic regression analysis to identify the main statistically significant associated factors of diarrhea using Stata version 14. The overall prevalence rate of experiencing diarrhea was 17.7% [95% CI: 15.4, 20.2] in the Amhara Regional State. The multivariable logistic regression model analysis indicated that the risk factors are fourth and above birth order [AOR = 2.95, 95% CI (1.483, 5.85)], gender of child (being male) [AOR = 1.66, 95% CI (1.144, 2.41)], no education level of mother’s [AOR = 4.7, 95% CI (1.01, 22.0)], being age of child 7–11 [AOR = 3.33, 95% CI (1.58, 7.01)] and 12–23 month [AOR = 2.17, 95% CI (1.11, 4.22)], mother’s age at 15–19 years [AOR = 12.2, 95% CI (2.986, 50.2)], mother’s age at 20–24 years [AOR = 6, 95% CI (1.758, 20.8)], and mother’s age at 25–29 years [AOR = 4.48, 95% CI (1.41, 14.2)], and five and greater than family size [AOR = 0.53; 95% CI (0.343, 0.84)] were statistically significant associated with a higher risk of diarrhea. The prevalence of diarrhea in the Amhara Regional State was higher than that at the national level. The study identified gender of a child, education level of the mother’s, birth order, family size, mother’s age, and child’s age as risk factors for diarrhea in children under-five.
- 18 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-9
Open AccessPrevalence of diarrheal and its associated factors among children aged under-five years in Amhara Regional State, Ethiopia: a cross-sectional study
Diarrhea is a major health problem in Ethiopia, and the Amhara Regional State is experiencing the highest prevalence rate of diarrhea. Therefore, this study was designed to assess the prevalence and risk factors attributed to diarrhea among children under-five in the Amhara Regional State. The study employed descriptive statistics and multivariable logistic regression analysis to identify the main statistically significant associated factors of diarrhea using Stata version 14. The overall prevalence rate of experiencing diarrhea was 17.7% [95% CI: 15.4, 20.2] in the Amhara Regional State. The multivariable logistic regression model analysis indicated that the risk factors are fourth and above birth order [AOR = 2.95, 95% CI (1.483, 5.85)], gender of child (being male) [AOR = 1.66, 95% CI (1.144, 2.41)], no education level of mother’s [AOR = 4.7, 95% CI (1.01, 22.0)], being age of child 7–11 [AOR = 3.33, 95% CI (1.58, 7.01)] and 12–23 month [AOR = 2.17, 95% CI (1.11, 4.22)], mother’s age at 15–19 years [AOR = 12.2, 95% CI (2.986, 50.2)], mother’s age at 20–24 years [AOR = 6, 95% CI (1.758, 20.8)], and mother’s age at 25–29 years [AOR = 4.48, 95% CI (1.41, 14.2)], and five and greater than family size [AOR = 0.53; 95% CI (0.343, 0.84)] were statistically significant associated with a higher risk of diarrhea. The prevalence of diarrhea in the Amhara Regional State was higher than that at the national level. The study identified gender of a child, education level of the mother’s, birth order, family size, mother’s age, and child’s age as risk factors for diarrhea in children under-five.
- Open Access
- 6 November 2024
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 13 (1) , 1-12
WHO/INRUD prescribing indicators with a focus on antibiotics utilization patterns at outpatient department of Adigrat general hospital, Tigrai, Ethiopia: a retrospective cross-sectional study
The World Health Organization (WHO) defines rational use of drug as a state in which medications are received by patients appropriately according to their clinical needs and individual requirement, for adequate period and at the right cost. More than 50% of all medicines are prescribed, dispensed, or sold inappropriately worldwide. This study aimed to evaluate the prescribing patterns in Adigrat general hospital, Tigrai, Ethiopia. A retrospective cross-sectional study was done to evaluate prescription patterns. A systematic random sampling technique was used to select 600 prescriptions and the prescriptions were reviewed using WHO/International Network of Rational Use of Drugs prescribing indicators. Data was collected from prescriptions dispensed from 01 March 2023 to 30 March 2024 at outpatient pharmacy of Adigrat general hospital. Data was analyzed using SPSS version 21 and a p-value < 0.05 was declared statistically significant. A total of 1088 medicines were prescribed in 600 prescription encounters, giving an average number of 1.8 (± 0.83) medicines per encounter. The percentage of medicines prescribed by generic name was 91.5% while 98.7% of the medicines were prescribed from essential medicine list (EML). Besides, the percentages of encounters containing at least one antibiotic and one injection were 44.5% and 7.2%, respectively. A total of 340 antibiotics were prescribed in 267 encounters. Penicillins (34.4%), macrolides (23.8%) and fluoroquinolones (17.1%) were the most prevalent antibiotics classes. The “Access” and “Watch” groups covered 54.4% and 45.6% of the total antibiotics prescribed, respectively. Being under 18 years old [Adjusted Odds Ratio (AOR): 9.830, CI: 4.062–23.786], being prescribed with three medicines (AOR: 3.247, CI: 1.571–6.708) and certain diagnosis like diseases of the respiratory system (AOR: 3.750, CI: 2.136–6.584) were significantly associated with antibiotic prescribing. This study showed deviations of prescribing patterns from WHO standards. The percentage of prescriptions with antibiotic was far from WHO optimal value. The use of antibiotics from “Access” group was below WHO standard. The percentage of medicines prescribed by generic name and the percentage of encounters with injection also deviated from WHO standard. Antibiotics prescribing showed significantly association with age, number of medicines and certain diseases.
- 6 November 2024
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 13 (1) , 1-12
Open AccessWHO/INRUD prescribing indicators with a focus on antibiotics utilization patterns at outpatient department of Adigrat general hospital, Tigrai, Ethiopia: a retrospective cross-sectional study
The World Health Organization (WHO) defines rational use of drug as a state in which medications are received by patients appropriately according to their clinical needs and individual requirement, for adequate period and at the right cost. More than 50% of all medicines are prescribed, dispensed, or sold inappropriately worldwide. This study aimed to evaluate the prescribing patterns in Adigrat general hospital, Tigrai, Ethiopia. A retrospective cross-sectional study was done to evaluate prescription patterns. A systematic random sampling technique was used to select 600 prescriptions and the prescriptions were reviewed using WHO/International Network of Rational Use of Drugs prescribing indicators. Data was collected from prescriptions dispensed from 01 March 2023 to 30 March 2024 at outpatient pharmacy of Adigrat general hospital. Data was analyzed using SPSS version 21 and a p-value < 0.05 was declared statistically significant. A total of 1088 medicines were prescribed in 600 prescription encounters, giving an average number of 1.8 (± 0.83) medicines per encounter. The percentage of medicines prescribed by generic name was 91.5% while 98.7% of the medicines were prescribed from essential medicine list (EML). Besides, the percentages of encounters containing at least one antibiotic and one injection were 44.5% and 7.2%, respectively. A total of 340 antibiotics were prescribed in 267 encounters. Penicillins (34.4%), macrolides (23.8%) and fluoroquinolones (17.1%) were the most prevalent antibiotics classes. The “Access” and “Watch” groups covered 54.4% and 45.6% of the total antibiotics prescribed, respectively. Being under 18 years old [Adjusted Odds Ratio (AOR): 9.830, CI: 4.062–23.786], being prescribed with three medicines (AOR: 3.247, CI: 1.571–6.708) and certain diagnosis like diseases of the respiratory system (AOR: 3.750, CI: 2.136–6.584) were significantly associated with antibiotic prescribing. This study showed deviations of prescribing patterns from WHO standards. The percentage of prescriptions with antibiotic was far from WHO optimal value. The use of antibiotics from “Access” group was below WHO standard. The percentage of medicines prescribed by generic name and the percentage of encounters with injection also deviated from WHO standard. Antibiotics prescribing showed significantly association with age, number of medicines and certain diseases.
- Open Access
- 18 June 2020
- Published by Springer Nature in Research Square
Comparative In Vitro Quality Evaluation of Different Brands of Ibuprofen Tablets Marketed in Mekelle, Ethiopia
Objective: Quality of pharmaceutical products is required to guarantee their safety and efficacy. The aim of this study was to evaluate the physicochemical quality attributes of different brands of ibuprofen tablets marketed in Mekelle, Ethiopia. The methods stated in the British Pharmacopeia were adopted for weight uniformity, hardness, friability, disintegration test and assay of drug content. Dissolution test was also carried out as stated in the United States Pharmacopeia. To compare dissolution profile, statistical analysis of drug release at different time points were employed. Results: All the brands were found with acceptable pharmacopeial specifications for weight uniformity, friability, hardness, assay of drug content and dissolution test. Six brands fulfilled the pharmacopeial requirements of disintegration test while one brand failed to disintegrate as per the BP specification. However, there were statistically significant difference in weight, hardness, disintegration, dissolution and amount of drug content among the tested samples. Thus, from this study we can conclude that all the products fulfilled the required quality evaluation parameters as stipulated in pharmacopeias except one brand which failed the disintegration test. However, the in vitro dissolution profile indicated that there may be a potential bio-in equivalence among the pharmaceutical products.
- 18 June 2020
- Published by Springer Nature in Research Square
Open AccessComparative In Vitro Quality Evaluation of Different Brands of Ibuprofen Tablets Marketed in Mekelle, Ethiopia
Objective: Quality of pharmaceutical products is required to guarantee their safety and efficacy. The aim of this study was to evaluate the physicochemical quality attributes of different brands of ibuprofen tablets marketed in Mekelle, Ethiopia. The methods stated in the British Pharmacopeia were adopted for weight uniformity, hardness, friability, disintegration test and assay of drug content. Dissolution test was also carried out as stated in the United States Pharmacopeia. To compare dissolution profile, statistical analysis of drug release at different time points were employed. Results: All the brands were found with acceptable pharmacopeial specifications for weight uniformity, friability, hardness, assay of drug content and dissolution test. Six brands fulfilled the pharmacopeial requirements of disintegration test while one brand failed to disintegrate as per the BP specification. However, there were statistically significant difference in weight, hardness, disintegration, dissolution and amount of drug content among the tested samples. Thus, from this study we can conclude that all the products fulfilled the required quality evaluation parameters as stipulated in pharmacopeias except one brand which failed the disintegration test. However, the in vitro dissolution profile indicated that there may be a potential bio-in equivalence among the pharmaceutical products.